Avdoralimab (IPH 5401) is a humanized monoclonal antibody targeting Complement C5a receptor 1 (C5aR1), used in research on bullous pemphigoid and chronic urticaria.
Purity:
>95%
CAS Number:
[2226393-85-5]
Target:
Complement System
* VAT and and shipping costs not included. Errors and price changes excepted